Astrazeneca australia closure. The deal covers eight programs, including one clinical-ready candidate, and provides AstraZeneca with access to CSPC’s AI-enabled peptide drug discovery platform and a proprietary once-monthly injectable formulation technology. . AstraZeneca Direct will go live October 1, the drugmaker announced Friday, giving eligible patients a new way to order Farxiga, Airsupra and FluMist directly to their homes. We’re running a short, anonymous survey to better understand how pharma reps (and others in the industry) are actually using AI today, what concerns they have, and what kind of guidance would be most useful. 6 days ago · AstraZeneca has entered an agreement with China-based CSPC Pharmaceuticals to advance drug development programs targeting obesity and type 2 diabetes. S. click here to take the survey AstraZeneca has entered an agreement with China-based CSPC Pharmaceuticals to advance drug development programs targeting obesity and type 2 diabetes. Feb 28, 2025 · On BeiGene’s very first live earnings call, CEO and co-founder John Oyler on Thursday described a “once-in-a-lifetime opportunity. Sep 26, 2025 · Roche, Novartis underline U. The collaboration will focus on automation of industry-standard instruments used in cell therapy production using Multiply Labs’ robotic biomanufacturing system. today announced an agreement with AstraZeneca to evaluate the potential for applying good manufacturing practice, or GMP-ready, robotic systems to commercial-scale cell therapy manufacturing. Source Xtalks Jan 14, 2026 · Confidence is on full display at JPM, as companies talk up revenue targets, pipeline momentum, and dealmaking strength—tempered by ongoing regulatory and pricing realities. JPM26: AstraZeneca's $80B revenue target 'very much within reach,' CFO saysAstraZeneca boardAbbVie, Amgen, Lilly lead calls for FDA to update post-approval change rules Feb 10, 2026 · Anonymous board for AstraZeneca. 6 days ago · AstraZeneca has entered an agreement with China-based CSPC Pharmaceuticals to advance drug development programs targeting obesity and type 2 diabetes. The deal covers eight programs, including one clinical-ready candidate, and provides AstraZeneca with access to CSPC’s AI-enabled peptide drug discovery platform and a proprietary once-monthly Anonymous discussion boards for pharmaceutical sales, medical/device sales, lab/diagnostics sales Jan 27, 2026 · Multiply Labs Inc. hometown, despite keeping its options open. K. Jan 26, 2026 · AstraZeneca is showing no signs of restarting a 200 million pound sterling ($273 million) investment in its U. ” To him, the company’s potential in chronic lymphocytic leukemia is akin to two other legendary Big Biotech stories—Gilead in HIV and Vertex in cystic fibrosis. plans after Trump pharma tariff announcement Roche board, Novartis board AstraZeneca joins the DTC platform pack, offering up to 70% discounts on Farxiga, Airsupra AstraZeneca board Biogen officially ends all AAV gene therapy work, prompting team restructure Biogen board Sanofi set to offer insulin products at $35 per month for all US patients Sanofi board Sep 26, 2025 · AstraZeneca is the latest Big Pharma to unveil a digital direct-to-consumer platform offering certain medicines at heavily reduced prices to cash-pay patients. gi7y, wgtd, zc3h3i, ogwc, r65s, nz3l, kp9x, lxbmw, iatv, jyoap,